ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 223 participants.

Also called NCT03295734

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 223 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03295734
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03295734. Randomized; quadruple masking; primary purpose prevention. Start 2018-05-29 (actual); primary completion 2024-09-19 (actual). Results posted on 2025-07-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension
Acronym
ACES
Condition
Hypertension
Condition
Aging
Condition
Sedentary Lifestyle
Intervention (Behavioral)
Aerobic exercise
Intervention (Drug)
Perindopril
Intervention (Drug)
Losartan
Intervention (Drug)
HCTZ
Lead sponsor
University of Alabama at Birmingham (class: other)
Collaborator
University of Colorado, Denver (class: other)
Collaborator
AdventHealth Translational Research Institute (class: other)

Record details

Record id
cardio:ct-nct03295734
Content hash
213e8047b6d30eccc60f3840bee867402cca9788dd27fee38f700263bd4c2b8e